| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1024 |
| Trial ID | ChiCTR2300075912 |
| Disease | B-Cell Non-Hodgkin's Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Not Recruiting |
| Title | HD CD19 CAR-T Therapy in Patients with Refractory or Relapsed Aggressive B-cell Non-Hodgkin Lymphoma: A Phase Ib/II Clinical Trial |
| Year | 2023 |
| Country | China |
| Company sponsor | Department of Hematology, Institute of Hematology, Changhai Hospital, Naval Medical University |
| Cohort 1 | |||||||||
|
|||||||||